Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Joins HHS Transition Team; Will Next Stop Be FDA?

Dec 02 2016

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Part B Demo Concerns Unite Policy Experts Across Political Spectrum

Apr 08 2016

Califf Says He Doesn't Need To Fight To Stay

Apr 18 2016

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

FDA Orphan-Only Review Division Could Speed Access, Gottlieb Suggests

May 24 2016

Califf Maintains Desire To Stay At FDA, But Would Either Presidential Candidate Keep Him?

Nov 05 2016

FDA Appears Close To Beginning Trump Transition Process

Nov 30 2016

Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform

Nov 30 2016

Why Generic EpiPen Is Not The Answer – Until FDA Says It Is

Aug 29 2016

Related Companies

Viatris Inc.

Additional Topics

United States FDA Elections Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.